TNFSF10 and cancer: Some chemotherapeutic agents can augment TRAIL-mediated apoptosis in cancer cells when co-administered with TRAIL in vitro and in vivo [16, 17, 21, 32–35], but these treatments rely on the intrinsic apoptotic pathway and risk failure because of the acquired defects in the cell death machinery of tumors found in relapsed cancer patients.